True North Buys 2.44% Stake In Biocon Biologics At $3 Billion Valuation
An employee in protective clothing works inside the research and development center at the Biocon Ltd. campus in Bengaluru. (Photographer: Dhiraj Singh/Bloomberg)

True North Buys 2.44% Stake In Biocon Biologics At $3 Billion Valuation

True North has acquired a stake in Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., valuing the company at $3 billion.The homegrown private equity fund acquired a 2.44 percent minority sta...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.